The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of infusional 5-fluorouracil, doxorubicin, and mitomycin-C (iFAM) chemotherapy and analysis of prognostic factors in previously treated advanced hepatocellular carcinoma.
Kyu-Hyoung Lim
No relevant relationships to disclose
Sae-Won Han
No relevant relationships to disclose
Do-Youn Oh
No relevant relationships to disclose
Seock-Ah Im
No relevant relationships to disclose
Tae-You Kim
No relevant relationships to disclose
Yung-Jue Bang
No relevant relationships to disclose